5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis
Most Cited Paper
in RNA modifications and cancer
18 Months Post-Publication
Class of 2026
“5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/rna-modifications-and-cancer/2026/
Topics
5-methylcytosine (m5C) · MALAT1 · sorafenib resistance · hepatocellular carcinoma · ELAVL1 · SLC7A11 · ferroptosis · NSUN2 · ALYREF · mRNA stability · mRNA stability · cytoplasmic translocation · MALAT1-IN1 · 5-methylcytosine (m5C) · long non-coding RNAs · NSUN2/ALYREF/MALAT1 signaling axis · MALAT1/ELAVL1/SLC7A11 signaling axis · sorafenib-induced ferroptosis · epigenetic mechanisms
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited RNA modifications and cancer Papers, Class of 2026. https://pri.pepkio.com/top-papers/rna-modifications-and-cancer/2026. Accessed 2026-07-22. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459